HB 22-1344 Colorado House · 2022 Regular Session

FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use

Summary
The act states that if the United States food and drug administration approves a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA), and if that medicine has been placed on a schedule of the federal "Controlled Substances Act", other than schedule I, or has been exempted from one or more provisions of such act, then thereafter prescribing, dispensing, transporting, possessing, and using that prescription drug is legal in Colorado only if the medicine is possessed by a person authorized to legally possess such a controlled substance in Colorado. (Note: This summary applies to this bill as enacted.)
Bill status signed all 5 stages cleared
Introduction
Mar 2022
Committee Review
Apr 2022
House Passage
Apr 2022
Senate Passage
Apr 2022
Signed into Law
Jun 2022
Introduced Mar 28, 2022 Signed Jun 8, 2022
Floor votes · Senate Apr 29, 2022 · House Apr 8, 2022

How they voted

330
Passed · 1 other
Total votes 34
Apr 29, 2022
D Democratic20
19 Yea 1
95% Yea
R Republican14
14 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
12
Key actions
5
Committee
2
Jun 8, 2022
Signed into law
Governor Signed
executive
Apr 29, 2022
Upper · Passed
Senate Third Reading Passed - No Amendments
upper
Apr 27, 2022
Upper · Passed
Senate Committee on Health & Human Services Refer Unamended - Consent Calendar to Senate Committee of the Whole
upper
Apr 13, 2022
Introduced
Introduced In Senate - Assigned to Health & Human Services
upper
Apr 8, 2022
Lower · Passed
House Third Reading Passed - No Amendments
lower
Apr 5, 2022
Lower · Passed
House Committee on Public & Behavioral Health & Human Services Refer Amended to House Committee of the Whole
lower
Mar 28, 2022
Introduced
Introduced In House - Assigned to Public & Behavioral Health & Human Services
lower
4 primary · 0 co-sponsors

Sponsors